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Dear Colleagues
Welcome to the Fifth Annual Conference for the Centre for Palliative Care
Research and Education.
The CPCRE Annual Research Conference aims to provide the palliative
community in Queensland with an opportunity to discuss some of the latest
research in the field of palliative care. The research presented at this year’s
Conference covers a broad spectrum of issues in palliative care education, 
practice, and policy.
We hope you find the Conference interesting, challenging, and enjoyable.
Warm Regards
Professor Patsy Yates
Acting Centre Director
Director of Research
Centre for Palliative Care
Research and Education

The Centre for Palliative Care
Research and Education
The Centre for Palliative Care Research and Education (CPCRE) is an
initiative of Queensland Health that improves Queensland palliative
care services through research and education.
To achieve these aims, the CPCRE operates as a ‘centre without walls’,
committed to building and fostering partnerships with the palliative care
community in its endeavours.
The key functions of CPCRE are to:
• Develop the capacity of the palliative care work force 
to provide quality palliative care
• Improve the links between research and practice in 
palliative care
• Undertake research to enhance the quality of 
palliative care
• Provide information which supports the delivery of palliative
care services
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Palliative Medicine: A Practice of Evidence or Experience?
MIchael Ashby
Director of the Centre for Palliative Care
St Vincent’s Hospital, Melbourne
This paper will suggest that palliative care medical practice is seldom
driven by research findings and if it is, these are unlikely to be from work
by the field itself.  Practice changes more as a result of case experience,
both personal and from case series.  Increasingly, innovations (good and
not so good) are transmitted by internet groups such as palliativedrugs.com
rather than by journal articles and trials.  New approaches to patient
management are rapidly tested out in practice and transmitted around the
world.  The expensive and time-consuming nature of clinical trials means
that many of these are never tested in this rigorous way.  The only arbiter
seems to be the Canadian historian Michael Ignatieffs covenant with his
readers: “I have found this, now is it true for you?”
The modern evidence-based medicine movement has tried to imbue the
whole of medicine with a rigorous approach to practice based on good
quality studies and this is clearly correct.  However, all good ideas have the
potential to overshoot and become oppressive.  Many questions and therapies
will never be subjected to clinical trials but will rise or fall on personal or
local experience.  Whilst it seems without question that good quality trials
should be designed for important therapeutic questions, it is disastrous, if
clinical experience is trivialised or down-graded.  Surely the first rule of
science is to describe what you see.  Informed and self-critical clinical
experience is the cornerstone of all that we do, and should be harnessed.
Unlike most other health specialties, palliative medicine does not have its
own unique basic scientific grounding, methodology or technology.  It
offers instead specialist practitioners and teams with unique attitude-
knowledge-skill mixes designed to meet the needs and wishes of their
clients.  These services are in a unique position to assist in the conduct of
research and may have valuable ideas for projects, but they are often
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7poorly equipped to conduct research themselves, and this expertise usually
has to be brought in. 
Most services have little time or aptitude for research but there are
increasing pressures upon them to engage in it. Given the parlous state of
the workforce in Australia and other countries, over-ambitious research
expectations can be burdensome and often fail to deliver useful results.  
The study of palliative care requires collaborative inputs from diverse
disciplines and methodologies, depending on the question being asked, a
fact that the most productive and successful research groups realised a long
time ago.  Everyone agrees that research collaborations are the way to go.
However, they have to answer relevant questions, with realistic
methodologies and time-lines and the resources have to be present at the
service level to do the work.  
Most importantly, all practitioners and services should ask whether they audit
their results, read widely and record their own experiences.  A culture of
healthy self-criticism and openness to new ideas is essential to the growth of
any credible specialty.  Furthering of local and global knowledge is
everyone’s business and not the preserve of a research elite, but not everyone
can or should do their own research. Services will join in, if they have the
resources to do so and the study is seen to be relevant. This is the challenge.
 
8Palliative Care Services Provision Within Brisbane South: 
A Prospective Audit
Liz Reymond1 , Fiona Israel2 and Margaret Charles3
1Palliative Care Specialist Brisbane, South Palliative Care Collaborative
2Clinical Nurse Consultant (Research), Brisbane South Palliative Care  
Collaborative
3Department of Psychology, Sydney University
The number of patients within the QEII Hospital Health Service District
requiring palliative care is rising due to acceptance of supportive palliative
care for a range of chronic conditions and because of the increasing
incidence of cancer in our ageing population. Anecdotal reports have
suggested that it is difficult to meet existing, let alone projected, palliative
care service requirements in this area. The Brisbane South Palliative Care
Collaborative (BSPCC) designed an audit and mapping study to describe
current palliative service capacity, client profiles and outcomes. Such
information can inform the design and delivery of future services.
The 2-month, prospective snapshot audit included all new palliative
admissions across in-patient and community-based sites, hospital re-
admissions and hospital out-patient episodes of care for patients referred to
any of the six government and non-government service providers covering
the catchment area. An episode of care was defined as the period between
the admission and discharge of a patient from any service. Information
collected included patient demographics such as age, sex, Indigenous
status, dominant language and primary diagnosis. Referral patterns
including referral source and reason for referral were documented. Service
provision characteristics such as initial service provider, numbers of
contacts with service providers and lengths of stay were collected.
Outcomes of episodes of care such as place of death, transfer to hospice or
discharges out of the audit area were also documented. In addition, the
study involved other components including mapping of service
characteristics and staffing levels against Palliative Care Australia
standards, focus groups of staff and bereaved lay-carers and interviews
with palliative care patients to explore their satisfaction with current
service provision. Ethics approval involved five different committees.
This paper will present some of the process and operational issues
associated with the collection of the data and some of the findings.
9Development of a Continuous Subcutaneous Infusion Order and
Administration Chart for Opoids and Other Medications Used in
Palliative Care Based on Medication Safety Principles
Tony Hall
Team Leader, High Risk Medications and Systems
Safe Medication Practice Unit
Royal Brisbane and Women’s Hospital
The Safe Medication Practice Unit was established in 2005 continuing
work that had been undertaken in developing a number of principles and
products enhancing a safety-based approach to all aspects of medication
practice (i.e., prescribing, dispensing, administration and communication).
These products included development of a Queensland Health statewide
standard medication chart that has since been chosen as the template for a
National Implementation of Medication Chart Project established in all
states under the auspices of the then Australian Council for Safety and
Quality in Health Care.
The principles used were enshrined in the Medication Safety Collaborative
model used by the Council:
• Collaboration
• Use of the PDSA (Plan, Do, Study, Act) cycle
• Basing changes upon iterative observation and study of existing 
processes and process failures
• Appropriate use of human error engineering principles of forcing 
function, standardisation, policy development and education
Opiates have long been recognised as medications with High Risk potential
for harm. Opioid use is a common therapeutic approach in palliative care
and in the use of continuous subcutaneous infusions (csci) of opioids and
other medications, including sedative agents, is a common feature of
palliative care within Queensland’s health care facilities.
A variety of iterations in form design were created, discussed and user-
tested with key stakeholders from Palliative Care physician, nursing and
pharmacy focus groups and clinical teams, changes made and observational
audits followed the trial of these documents and this process continues
using the PDSA cycle. The latest iteration will be presented together with
the outcomes from its current trial process.
A mini HEAPS (Human Error and Patient Safety) examination of a large
number of clinical incidents involving the administration of opioids and
sedatives by continuous sub-cutaneous infusion revealed a number of
failure points in currently used prescribing, administration and
documentation methods including failures in prescribing, prescribing
review, formulation and calculation, administration and patient observation
associated with inexperience and conflicting demand on experienced staff.
The current form was designed to address these issues.
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Take Away the Pain but Leave Me Whole: Aboriginal Perspective on
Palliative Care
Deborah Prior
Director of Learning and Development
CPCRE
Epidemiological studies have demonstrated a disproportionate morbidity
and mortality rate affecting the Aboriginal population and paradoxically
social studies have identified conflicting cultural paradigms as a major
barrier to palliative care for this population.  These findings are supported
by anecdotal and survey evidence that Aboriginal people remain under-
represented in the palliative care patient population despite efforts to
develop culturally appropriate services.  One explanation is that the
meaning of ‘cultural appropriateness’ has not been sufficiently defined
from the Aboriginal perspective.   Culturally appropriate services are
informed by an understanding of Aboriginal perspective of concepts such
as, palliation, communicating ‘bad news’, grief, spirituality, death and
bereavement.  Exploring the phenomena of cultural perspectives,
particularly relating to end-of-life care, requires a qualitative approach that
encourages dialogue about the issues in question.
In this paper, I present the findings of a qualitative study that explored the
cultural difference underpinning Aboriginal peoples’ ambivalence toward
cancer-palliative care.  A key finding of my research was that while
Aboriginal people want to take advantage of medical knowledge and
treatment in palliative care, they question why cultural values for an
holistic approach should be compromised in the process. 
A Pilot Study of Haloperidol for the Control of Nausea and Vomiting
in Cancer Patients with Advanced Cancer
Janet Hardy1, Anthony Herbert2, Rohan Vora3 and Jane Holt3
1Clinical Research Program Leader, CPCRE;
Director of Palliative Care, Mater Health Services, Brisbane
2Palliative Care Registrar, Mater Health Services, Brisbane
3Advanced Trainee Registrar, Chapter of Palliative Medicine,
Day Oncology Registrar, Mater Adult Hospital, Brisbane
4Research Nurse, Mater Health Services, Brisbane
INTRODUCTION
Nausea and vomiting (N/V) are common symptoms in patients with
advanced disease. Haloperidol is often used to manage N/V, especially
when no other agent is specifically indicated or where the cause of the N/V
is unclear or unknown. There is no evidence, however, other than
anecdotal, to support its common use.
AIM
The study aims to determine the efficacy of haloperidol in controlling N/V
in patients with advanced cancer.
METHODS
The study has been designed to reflect routine clinical practice in palliative
care and the difficulties in conducting research in this patient group. All
patients known to the palliative care service, able to consent and complete
questionnaires, with N/V for which there is no specific treatment are eligible
to enter. Patients may be antiemetic naive or have been exposed to other
drugs. Haloperidol is prescribed either orally or parenterally according to the
severity of the condition at three dose levels to a maximum of 6mg/day.
Breakthrough doses are available to a maximum of 1mg/day. Nausea,
vomiting and toxicity are recorded at baseline and daily for 5 days on a 4-
point scale from “none” to “very much”. Complete and partial responses are
defined as a reduction in baseline score to zero or less than baseline
respectively. Patients are withdrawn if N/V is not controlled or side-effects
are intolerable.
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RESULTS
Interim results will be presented. Recruitment to date has been slow. The
primary reason for ineligibility has been the presence of a specific cause of
N/V for which a particular antiemetic is indicated. Another observation has
been of the day-to-day variability in N/V and the number of changes in
concomitant medications during the 5-day trial period that might have a
bearing on N/V control.
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The Link Medical Officer Project
Dr Rosemary Ramsay
Link Medical Officer, Brisbane South Palliative Care Service
Brisbane South Community Health Service QEIIHHSD
The primary objective of the project is to decrease the numbers of patients
being readmitted to acute care facilities whilst awaiting contact from a
Specialist Palliative Care Service. Secondary objectives include improvement
in symptom management (including physical, psychosocial and spiritual
distress) and support for carers.
Community-based Specialist Palliative Care Services providing home care
on a 24-hour basis face increasing difficulties in servicing their patients with
the resources available. Patients discharged from acute care facilities referred
to Community-based Specialist Palliative Care Service providers may face a
delay in commencement of service in our region. The Link Medical Officer
and the BSPCS nurses can maintain contact with these clients after
discharge. The Link Medical Officer is able to visit clients at home. The
patient’s choice of place of care is of prime importance. General practitioners
and community service providers are also supported. 
The outcome of the project will be measured with an audit 6 months after
commencement. The audit will provide measures of outcomes such as the
number of palliative patients seen by the BSPCS returning to acute hospitals
after discharge, numbers of patients seen by the Link Medical Officer and
other patient outcomes.
Project funded for 12 months by the Australian Government Department of
Health and Ageing-Local Palliative Care Grants Program Round One- Fit-out
and Equipping Premises and Transition-to-Home Support for the project
“Enhancing Palliative Care Capacity across the Brisbane South Area-Medical
Link’ Program”.
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Understanding Factors Contributing to Nausea in Advanced Cancer:
Clinical and Patient Perspectives
Patsy Yates1, Alexandra Clavarino2, Geoff Mitchell2, Peter Hudson3 and
Peter Martin3
1Acting Director, CPCRE, Queensland University of Technology
2University of Queensland
3Centre for Palliative Care, St Vincent’s Hospital, Melbourne
Significant advances have been made in the management of chemotherapy
related nausea and vomiting. Less attention has been given to
understanding nausea experienced by people with advanced cancer. 
The purpose of this multi-method study was to identify clinical and
psychosocial factors that are associated with advanced cancer patients’
reports of nausea. Two tools were developed on the basis of findings from
a systematic review of the literature and qualitative interviews. The tools
included: a Clinical Assessment Tool completed by clinicians to indicate
which of 21 factors were contributing to a patient’s nausea and a
structured, interviewer-administered questionnaire completed by patients,
which comprised numeric rating scales to assess nausea severity and
impact (0-10), and checklists to rate on a five point scale (not at all–very
much) the extent to which 17 clinical, emotional and environmental factors
contributed to nausea. A total of 110 (42.3%) were recruited from three
inpatient and five community palliative care services. Of the patients
screened during the data collection period, 19.7% had experienced nausea
in the past week. Five out of the 12 factors were rated by more than 25%
of patients as contributing to nausea somewhat, quite a bit, or very much,
including: certain foods (41%), food/cooking odours (40%), stress (28%),
anxiety (27%), and movement (25%). Eleven of the 21 potential
contributing factors included in the clinical assessment were identified by
clinicians as being present in more than 25% of cases.  The most common
clinical factors identified (in patients with nausea) were: opioid use
(91.6%), pain (88.5%), GI cancer or metastases (56.8%), constipation
(55.8%), and abdominal distension (42.3%).  Nausea in advanced cancer is
a complex multi-faceted problem. The data obtained through this study
have the potential to enable the development of more targeted assessment
and intervention processes.
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Children with Advanced Neuroblastoma- Two Case Studies of
Paediatric Palliative Care
Anthony Herbert1 and Helen Irving2
1Palliative Care Registrar, Mater Health Services, Brisbane
2Director, Haematology; Oncology and Stem Cell Transplant Unit;
Banksia Unit, Royal Children’s Hospital, Brisbane 
We present the case studies of 2 children (a male aged 2 and a female aged
4) with stage IV neuroblastoma who received palliative care at the Royal
Children’s Hospital, Brisbane, in 2005.  One child completed intensive
treatment for neuroblastoma (i.e., chemotherapy, surgical debulking,
autologous bone marrow transplant and irradiation) before their disease
progressed.  The other child, whose disease progressed during treatment
with chemotherapy, did not undergo an autologous bone marrow transplant
because of this.  Pain management was difficult in both children but
achieved with parenterally-administered morphine (via a central line in one
child and subcutaneously in the other child). Both children received
palliative radiotherapy to try and alleviate pain symptoms. One child came
from a rural location within Queensland, which provided extra challenges
in his care.  Tele-medicine consultations facilitated communication with the
multi-disciplinary team that cared for this boy upon returning home. The
importance of cultural factors will also be explored as in the second case in
which the parents had grown up in an Asian country before moving to
Australia.  Developmental issues relevant to each child, particularly in
relation to activities which maximized quality of life (holidays, pets, play)
will be highlighted. Finally, support of the family during the bereavement
process will be emphasized.
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Developing a Simple, Integrated, ‘Self Report’, Multi-Disciplinary
Screening Tool to Assess Symptom Distress, Functional Status 
and Level of Social Support for Patients Attending a Day 
Oncology Service.
Rohan Vora1 and Anne Franks2
1Advanced Trainee Registrar, Chapter of Palliative Medicine,
Day Oncology Registrar
2Nurse Unit Manager, Day Oncology Unit
Mater Adult Hospital, Brisbane
BACKGROUND
As Day Oncology services become increasingly busy, ‘ad hoc patient
reports’ or ‘staff intuition’ is becoming increasingly inadequate to pick up
symptom distress, functional decline or social and community support needs
of patients and their families or carers. Increased numbers of elderly patients
are attending Day Oncology services. The current proportion of persons
over 65 in our population is predicted to increase from 12% to 20% over the
next 15 years. Hence, having adequate screening tools in Day Oncology
services to be able to pick-up and identify ‘at-risk’ elderly patients is
becoming increasingly important. A previous survey in the out-patient
department using an Allied Health Professional (AHP) screening tool found
that 79% of patients could benefit from an AHP intervention. Many patients
are spending more time attending oncology clinics or recovering from
chemotherapy as modern treatment is increasing length of survival (LOS) in
many cancers. Symptom distress often precludes the ability to engage in
meaningful and enjoyable activities between treatments.
AIMS
• To develop a simple and yet comprehensive, integrated,
multidisciplinary, ‘self report’ screening tool for all patients of a busy
Day Oncology service.
• To integrate this screening system into daily work routines, with
minimal added burden for currently busy Day Oncology staff.
• To maintain the quality of the Day Oncology service by targeting
multidisciplinary team interventions to provide care where it is most
needed and be able to assess the adequacy of this service in assessing
and reducing patient distress.
17
METHOD
• Analysis of previous work of the Mater AHPs in assessing the needs for
AHP interventions in Outpatient Oncology services.
• Literature search for existing, validated tools designed for screening a
Day Oncology patient population.
• Collaborative team meetings to derive and implement a comprehensive
symptom distress, functional status and social support screening tool for
Day Oncology.
FINDINGS
Many barriers exist to implementing screening tools such as time
constraints, lack of multidisciplinary care coordination, integration and
financing of multidisciplinary team interventions. There is a lack of
seamless integration into the community with overstretched, poorly funded
and inadequately trained community services. Patients and their
family/carers seem enthusiastic in accepting to partake in the “screening
tool process”.
CONCLUSION
There is a need for the integration of a screening tool in Day Oncology
with further “Care Pathway” processes. This requires the active
involvement of a broad multidisciplinary team. Support for the process also
needs to come from the ‘top of the service chain’ for any progress to occur.
Patients and their families/carers should be involved in the development of
symptom screening tools so that important issues affecting their QOL and
cancer journey experience can be addressed.
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Reluctance to Care: A Systematic Review and Conceptual Framework
Letty Burridge1, Sarah Winch2 and Alexandra Clavarino3
1Graduate StudentSchool of Population Health,
University of Queensland
2Nursing Director Research, Princess Alexandra Hospital, Brisbane
3Senior Research Fellow, School of Population Health,
University of Queensland
Primary lay carers are increasingly important in the care of patients with
cancer.  Many cancer survival rates are increasing, the demands placed
upon finite health resources are expanding, and home-based care is
growing in popularity.  This can make the lay cancer caregiving role both
complex and extended.  Powerful social norms place people under pressure
to care when the need arises, such as at the time of cancer recurrence when
the patient’s independence is diminishing.  The number of older carers is
increasing, while the willingness of younger family members to care can
no longer be assumed.  Potential carers may feel anything from highly
committed to not at all interested in the caregiving role, but any reluctance
may be hidden to avoid censure.  If caregiving reluctance leads to adversity
for carers or patients, then it is important to understand what makes
potential carers reluctant, how it is dealt with, and the consequences for all
concerned, in order to avert undesirable outcomes.  Caregiving reluctance
is neither rare nor new in Australia, but the topic is under-explored,
particularly in the cancer context, and the consequences are relatively
unknown.  The purpose of this review was to gain insights into caregiving
reluctance and its consequences, by asking the question:  What is known
about lay caregiving reluctance?  The findings were organised into four
major dimensions:  demographic, physical, psychological and social.
Three major outcomes were identified.  Definitive answers to the review
question remain elusive.  Choice seems to be a major indicator of
caregiving reluctance, although reluctance may not remain static over the
caregiving trajectory.  Recommendations for future research are identified.
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Assessment of Mater Adult Hospital Oncology “Right Of Private
Practice”(ROPP or Outpatients Clinic) Patients Allied Health
Professional Needs
Merilyn Tefay1 and Ann Crome2
1Acting Director of Occupational Therapy
2Senior Social Worker, Oncology
Mater Adult Hospital, Brisbane 
AIM
To determine whether oncology patients attending ROPP clinics would
benefit from allied health professional (AHP) intervention.
METHODS
Three (3) randomly-chosen half-day clinics were assessed with 64 patients
completing the revised `Allied Health Oncology Screening Tool’.
RESULTS
Sixty-three (98%) surveys were deemed eligible to be included. Seventy-
nine percent of patients screened were assessed as requiring one AHP
intervention with 65% of all patients screened required two or more AHP
interventions.  By discipline, the majority of patients indicated a need for
Social Work intervention (78%), followed by Occupational Therapy (66%),
Physiotherapy (56%) and Dietetics (40%).
DISCUSSION
Seventy-nine percent of patients attending ROPP clinics indicated a
requirement for AHP intervention.  These results are supported by previous
surveys conducted in day oncology that utilised related screening tools.
CONCLUSION
Patients attending Qld. Radium Institute ROPP clinics for appointments with
medical professionals are not currently receiving the multidisciplinary team
care that they require.  With 79% of patients attending ROPP requiring AHP
intervention as indicated through the MHS AHP oncology screening tool the
need for designated Allied Health Professional resources to these clinics is
clearly indicated.
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What are the Barriers to the Optimal Care of the Dying?
Janet Hardy
on behalf of the Queensland Palliative Care Research Group (QPCRG)
Clinical Research Program Leader, CPCRE; 
Director of Palliative Care, Mater Health Services, Brisbane 
INTRODUCTION
There have been significant improvements in the care of the dying over
recent years co-incident with the development of palliative care as a
specialty. However, it is acknowledged, especially by health professionals
in the field, that deficiencies remain. It is hoped that the identification of
barriers to a good death, can lead to system change and hence
improvement in end-of-life care.
METHOD
A list of potential barriers to optimal end-of-life care was provided by a
multi-professional focus group within a local palliative care service. Those
barriers considered most important were selected and refined by those
attending QPCRG meetings. The barriers were grouped into 7 categories
(i.e., those considered most relevant to patients, carers/relatives, society,
health professionals [non palliative care], health systems, care in the
community and residential aged-care facilities). QPCRG members
developed a survey that asked respondents to rate the level of importance
of the barriers in each category and to identify 3 barriers considered most
important over-all. Demographic information that included information on
the experience and health care setting of each professional was also
requested. Following ethics approval, the survey was sent to all those listed
as members of Palliative Care Queensland. 
RESULTS
The barriers to optimal care of the dying considered most important to a
range of health care professionals will be presented and correlated with the
age, sex, work experience and care setting of each respondent.
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